trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Prior SARS-CoV-2 infection gives lasting but incomplete protection against reinfection.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
6 sources for · 1 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that prior SARS-CoV-2 infection gives lasting but incomplete protection against reinfection?

Yes. A systematic review and a large national study report that prior SARS-CoV-2 infection gives strong but incomplete protection against reinfection, lasting roughly 10 months to over a year, though Omicron-era data show reinfection became relatively common.

Verdict: SUPPORTED · 6 sources for, 1 against · Last checked

The private library was unavailable for some searches in this check. Missing library results are not evidence against the claim.

Evidence for · 6
Get citation
Infection. (n.d.). en.wikipedia.org. https://en.wikipedia.org/wiki/Infection

Evidence against · 1
2022
Get citation
Keeling, M. J. (2022). Patterns of Reported Infection and Reinfection of SARS-CoV-2 in England. doi.org. https://doi.org/10.1101/2022.06.13.22276316

See more details
More for · 5
2022
Get citation
D, G., G, A., S, C., & SA, P. (2022). Correlates of protection against SARS-CoV-2 infection and COVID-19 disease.. doi.org. https://doi.org/10.1111/imr.13091

2025
Get citation
Chemaitelly, H., Ayoub, H. H., & Abu-Raddad, L. J. (2025). P-1948. Differential Patterns of Protection from Natural Infection against SARS-CoV-2 Reinfection in the Pre-Omicron and Omicron Eras. doi.org. https://doi.org/10.1093/ofid/ofae631.2107

2021
Get citation
N, K., NK, S., & JD, K. (2021). A Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat Infection.. doi.org. https://doi.org/10.1177/01632787211047932

Get citation
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity - PMC Lock. (n.d.). pmc.ncbi.nlm.nih.gov. https://doi.org/10.1016/j.envres.2022.112911

Get citation
SARS-CoV-2 seroprevalence and infection rate in Manila, Philippines prior to national vaccination program implementation: a repeated cross-sectional analysis. (n.d.). cir.nii.ac.jp. https://doi.org/10.1186/s41182-022-00468-7

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work